Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
Hematopoietic Stem Cell Transplant
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT05722210 - Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant | Biotech Hunter | Biotech Hunter